Cytomegalovirus prophylaxis with ganciclovir, acyclovir, and CMV hyperimmune globulin in liver transplant patients receiving OKT3 induction

Transplant Proc. 1995 Oct;27(5 Suppl 1):31-3.

Authors

J M Ham¹, S L Shelden, R R Godkin, M P Posner, R A Fisher

Affiliation

¹ Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0057, USA.

PMID: 7482814

No abstract available

Publication types

Comparative Study

MeSH terms

Acyclovir / therapeutic use*
Adolescent
Adult
Aged
Azathioprine / therapeutic use
Child
Child, Preschool
Combined Modality Therapy
Cyclosporine / therapeutic use
Cytomegalovirus Infections / epidemiology
Cytomegalovirus Infections / prevention & control*
Drug Therapy, Combination
Female
Ganciclovir / therapeutic use*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Infant
Liver Transplantation / immunology*
Male
Methylprednisolone / therapeutic use
Middle Aged
Muromonab-CD3 / therapeutic use*
Postoperative Complications / epidemiology
Postoperative Complications / prevention & control*
Prednisone / therapeutic use
Retrospective Studies

Substances

Immunoglobulins, Intravenous
Muromonab-CD3
Cyclosporine
Azathioprine
Ganciclovir
Prednisone
Acyclovir
Methylprednisolone